Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical WTPA vs HCPT After TURBT in Non-muscle Invasive Bladder Cancer
ChiCTR-TRC-12002638Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Nov 2012
- Modality
- Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of pseudomonas aeruginosa injection in bladder cancer and transitional cell carcinoma of the bladder (TCC) (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Recurrence rate. Started Nov 2012; status: completed.
02
Drugs
pseudomonas aeruginosa injection
03
Conditions
bladder cancertransitional cell carcinoma of the bladder (TCC)
Beyond the preview
Go deeper on ChiCTR-TRC-12002638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002638.